[go: up one dir, main page]

ES432106A1 - Procedimiento para la preparacion de d-homo-20-cetopregna- nos. - Google Patents

Procedimiento para la preparacion de d-homo-20-cetopregna- nos.

Info

Publication number
ES432106A1
ES432106A1 ES432106A ES432106A ES432106A1 ES 432106 A1 ES432106 A1 ES 432106A1 ES 432106 A ES432106 A ES 432106A ES 432106 A ES432106 A ES 432106A ES 432106 A1 ES432106 A1 ES 432106A1
Authority
ES
Spain
Prior art keywords
hydrogen
carbon
see formula
ketopregnanes
homo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES432106A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2360443A external-priority patent/DE2360443A1/de
Priority claimed from DE19742445161 external-priority patent/DE2445161A1/de
Application filed by Schering AG filed Critical Schering AG
Publication of ES432106A1 publication Critical patent/ES432106A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J63/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
    • C07J63/008Expansion of ring D by one atom, e.g. D homo steroids
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P33/00Preparation of steroids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Steroid Compounds (AREA)
ES432106A 1973-11-30 1974-11-20 Procedimiento para la preparacion de d-homo-20-cetopregna- nos. Expired ES432106A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2360443A DE2360443A1 (de) 1973-11-30 1973-11-30 D-homo-20-ketopregnane
DE19742445161 DE2445161A1 (de) 1974-09-19 1974-09-19 D-homo-20-ketopregnane ii

Publications (1)

Publication Number Publication Date
ES432106A1 true ES432106A1 (es) 1976-11-01

Family

ID=25766200

Family Applications (1)

Application Number Title Priority Date Filing Date
ES432106A Expired ES432106A1 (es) 1973-11-30 1974-11-20 Procedimiento para la preparacion de d-homo-20-cetopregna- nos.

Country Status (14)

Country Link
US (1) US4045574A (es)
JP (1) JPS5084561A (es)
AT (1) AT347611B (es)
CA (1) CA1030522A (es)
CH (1) CH618183A5 (es)
DD (1) DD115659A5 (es)
DK (1) DK134348C (es)
ES (1) ES432106A1 (es)
FR (1) FR2253512B1 (es)
GB (1) GB1494097A (es)
IE (1) IE40423B1 (es)
IL (1) IL46153A (es)
NL (1) NL7415577A (es)
SE (1) SE408426B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4879316A (en) * 1987-02-26 1989-11-07 The University Of Tennessee Research Corporation Interpenetrating polymer network ion exchange membranes and method for preparing same
US6787530B1 (en) 1996-08-23 2004-09-07 Monash University Use of pregnane-diones as analgesic agents
ES2271636T3 (es) * 2002-08-16 2007-04-16 PHARMACIA & UPJOHN COMPANY LLC Intermediarios de 5 androsten-3-ol esteroides y procedimientos para su preparacion.
US20070066579A1 (en) * 2002-08-16 2007-03-22 White Michael J 5-androsten-3beta-ol steroid intermediates and processs for their preparation
WO2014169836A1 (en) 2013-04-17 2014-10-23 Sage Therapeutics, Inc. 19-nor neuroactive steroids and methods of use thereof
BR112015026380A8 (pt) 2013-04-17 2019-12-31 Sage Therapeutics Inc esteróides de c21-n-pirazolil 19-nor c3,3-dissubstituídos e métodos de uso destes
US9725481B2 (en) 2013-04-17 2017-08-08 Sage Therapeutics, Inc. 19-nor C3, 3-disubstituted C21-C-bound heteroaryl steroids and methods of use thereof
CN117304245A (zh) 2013-04-17 2023-12-29 萨奇治疗股份有限公司 刺激神经活性的19-去甲类固醇及其使用方法
AU2014290400B2 (en) 2013-07-19 2019-12-05 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
EP3488852B1 (en) 2013-08-23 2020-10-28 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
US10246482B2 (en) 2014-06-18 2019-04-02 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
AU2015331597B2 (en) 2014-10-16 2020-04-30 Sage Therapeutics, Inc. Compositions and methods for treating CNS disorders
CN117024502A (zh) 2014-10-16 2023-11-10 萨奇治疗股份有限公司 靶向cns障碍的组合物和方法
EP3719029A1 (en) 2014-11-27 2020-10-07 Sage Therapeutics, Inc. Compositions for inducing sedation
DK3250210T3 (da) 2015-01-26 2021-03-08 Sage Therapeutics Inc Sammensætninger og fremgangsmåder til behandling af cns-forstyrrelser
WO2016134301A2 (en) 2015-02-20 2016-08-25 Sage Therapeutics, Inc. Neuroactive steroids, compositions, and uses thereof
NZ749664A (en) 2016-07-11 2025-08-29 Sage Therapeutics Inc C17, c20, and c21 substituted neuroactive steroids and their methods of use
JP7065825B2 (ja) 2016-07-11 2022-05-12 セージ セラピューティクス, インコーポレイテッド C7、c12、およびc16置換神経刺激性ステロイドおよびそれらの使用方法
MA51316A (fr) * 2017-12-22 2020-10-28 Sage Therapeutics Inc Compositions et méthodes permettant de traiter les troubles du snc
EP3902818A1 (en) 2018-12-05 2021-11-03 Sage Therapeutics, Inc. Neuroactive steroids and their methods of use
KR102821994B1 (ko) 2019-01-08 2025-06-19 쳉두 캉홍 파마슈티칼 코., 엘티디. 스테로이드 화합물, 및 이의 용도와 제조방법
AR119047A1 (es) 2019-05-31 2021-11-17 Sage Therapeutics Inc Esteroides neuroactivos como moduladores de gabaa y su uso en el tratamiento de trastornos del snc
TWI896548B (zh) * 2019-06-27 2025-09-11 美商賽吉醫療公司 用於治療cns病症之組合物及方法
WO2020264495A1 (en) * 2019-06-27 2020-12-30 Sage Therapeutics, Inc. Compositions and methods for treating cns disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2860158A (en) * 1954-10-18 1958-11-11 Sterling Drug Inc Compounds of the perhydrochrysene series and preparation thereof
US3686223A (en) * 1968-12-26 1972-08-22 Sterling Drug Inc D-homoestratrienes
US3833621A (en) * 1972-03-20 1974-09-03 Richardson Merrell Inc 3-keto-7(alpha,beta)-loweralkyl-delta5 steroids and process for preparing same

Also Published As

Publication number Publication date
AT347611B (de) 1979-01-10
SE7414960L (es) 1975-06-02
GB1494097A (en) 1977-12-07
DD115659A5 (es) 1975-10-12
IE40423L (en) 1975-05-30
DK604174A (es) 1975-07-28
ATA950774A (de) 1978-05-15
IL46153A (en) 1979-01-31
CA1030522A (en) 1978-05-02
NL7415577A (nl) 1975-06-03
FR2253512A1 (es) 1975-07-04
DK134348C (da) 1977-03-21
FR2253512B1 (es) 1978-02-03
IE40423B1 (en) 1979-05-23
IL46153A0 (en) 1975-02-10
SE408426B (sv) 1979-06-11
US4045574A (en) 1977-08-30
AU7586774A (en) 1976-06-03
JPS5084561A (es) 1975-07-08
CH618183A5 (es) 1980-07-15
DK134348B (da) 1976-10-25

Similar Documents

Publication Publication Date Title
ES432106A1 (es) Procedimiento para la preparacion de d-homo-20-cetopregna- nos.
ES448188A1 (es) Un procedimiento para la preparacion de acido lactico.
ES439720A1 (es) Procedimiento para la preparacion de 18-metil-19-nor-20-ce- topregnanos.
ES366943A1 (es) Procedimiento para la preparacion de derivados de 1-etil-3,3-dimetil-ciclohexano.
ES398036A1 (es) Procedimiento para la obtencion de derivados del acido 2- fosfono-butano-1,2-dicarboxilico.
GB1454489A (en) Paromomycin derivatives
ES420630A1 (es) Procedimiento para la preparacion de n-(furil-metil)-morfi-nanos.
ES441784A1 (es) Procedimiento para la preparacion de 7-hidroxi-estradioles.
ES402608A1 (es) Procedimiento para el desdoblamiento de racematos de d, 1- fenilpropanolamina con acidos opticamente activos.
ES432479A1 (es) Procedimiento para la preparacion de esteres dialcohilicos de acido malonico.
ES412799A1 (es) Un procedimiento para preparar alcoholes alcohilsulfonilme-tilbencilicos.
ES274909A1 (es) Procedimiento para la preparaciën de nuevos derivados de iminodibencilo
ES428228A1 (es) Procedimiento para la preparacion de 8alfa-estratrienos.
ES422877A1 (es) Procedimiento para la obtencion de derivados del acido prostanico.
ES425430A1 (es) Procedimiento para la preparacion de derivados de biciclo- alcano.
ES386553A1 (es) Procedimiento de preparacion de un nuevo derivado papavero-linico.
ES446837A1 (es) Procedimiento para la preparacion de sales de ester dimeti- laminoetilico de acido para-clorofenoxiacetico.
GB991474A (en) Novel steroid compounds and their preparation
ES422248A1 (es) Procedimiento para la preparacion de 7-cloro-1,2-dihidro-5-fenil - 1,4-benzodiazepin-2-onas.
ES423976A1 (es) Procedimiento para la preparacion de nuevas bencilaminas.
ES316644A1 (es) Metodo para formar un derivado con contenido de oxigeno de un compuesto insaturado.
ES390920A1 (es) Procedimiento para la preparacion de 4,5 alfa - oxido - gufa-20,22-dienolid-3-(ramnosido 2'83' - dialcohilortocarbo-natos).
ES446110A1 (es) Procedimiento para la preparacion de 10alfa, 11alfa-metilen-prostaglandinas.
ES376700A1 (es) Procedimiento para la preparacion de nuevos alcoholes o-a- nilino-feniletilicos substituidos.
ES344654A1 (es) Un procedimiento para la preparacion de un derivado de aci-do 3-indolilacetico.